FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2120332010> ?p ?o ?g. }

• W2120332010 endingPage "379" @default.
• W2120332010 startingPage "372" @default.
• W2120332010 abstract "Administration of an oral cephalosporin allowed advancement of the dosage of oral irinotecan. This study investigates whether administration of an oral cephalosporin increases the maximum tolerated dose (MTD) of intravenous irinotecan.Irinotecan was administered intravenously on Days 1-5 and Days 8-12 of a 21-day cycle with continuous oral cefpodoxime starting 2 days prior to irinotecan. Cohorts of 3-6 pediatric patients with refractory solid tumors were enrolled at 4 dosage levels, starting at the single-agent irinotecan MTD of 20 mg/m(2) /dose.The 17 evaluable patients received 39 courses of therapy. None of the patients treated with 20 mg/m(2) /dose experienced dose-limiting toxicity (DLT). One of six patients treated at 30 mg/m(2) /dose experienced dose-limiting neutropenia. Two of three patients treated with 45 mg/m(2) /dose and two of five treated with 40 mg/m(2) /dose experienced dose-limiting diarrhea, with associated dehydration and anorexia. Two unconfirmed partial responses were observed after one course in a patient with Ewing sarcoma and one with paraganglioma. A child with refractory neuroblastoma had disease stabilization through 12 courses of therapy. Median (range) systemic exposure to SN-38 at the MTD (30 mg/m(2) /dose) was 67 ng-h/mL (36 to 111 ng-h/mL).The MTD of intravenous irinotecan administered on a protracted schedule was increased by 50% from 20 to 30 mg/m(2) /dose with the addition of oral cefpodoxime. The most prominent DLT remained diarrhea. High interpatient variability in irinotecan pharmacokinetics was observed; however, SN-38 exposure at the MTD was greater than most reported exposures with the 20 mg/m(2) dosage." @default.
• W2120332010 created "2016-06-24" @default.
• W2120332010 creator A5012423746 @default.
• W2120332010 creator A5026099902 @default.
• W2120332010 creator A5028072367 @default.
• W2120332010 creator A5034374604 @default.
• W2120332010 creator A5043293908 @default.
• W2120332010 creator A5045180889 @default.
• W2120332010 creator A5050739458 @default.
• W2120332010 creator A5053244337 @default.
• W2120332010 creator A5060308592 @default.
• W2120332010 creator A5070962895 @default.
• W2120332010 creator A5073277560 @default.
• W2120332010 creator A5085620590 @default.
• W2120332010 date "2011-04-20" @default.
• W2120332010 modified "2023-10-14" @default.
• W2120332010 title "Dose escalation of intravenous irinotecan using oral cefpodoxime: A phase I study in pediatric patients with refractory solid tumors" @default.
• W2120332010 cites W1489029548 @default.
• W2120332010 cites W1566780686 @default.
• W2120332010 cites W1964421187 @default.
• W2120332010 cites W1972056781 @default.
• W2120332010 cites W1975854658 @default.
• W2120332010 cites W1984930240 @default.
• W2120332010 cites W1990450253 @default.
• W2120332010 cites W1991348994 @default.
• W2120332010 cites W1995024307 @default.
• W2120332010 cites W2001477876 @default.
• W2120332010 cites W2011909208 @default.
• W2120332010 cites W2021622287 @default.
• W2120332010 cites W2032117049 @default.
• W2120332010 cites W2032806260 @default.
• W2120332010 cites W2036094732 @default.
• W2120332010 cites W2040275378 @default.
• W2120332010 cites W2041066142 @default.
• W2120332010 cites W2044788942 @default.
• W2120332010 cites W2044952801 @default.
• W2120332010 cites W2060118888 @default.
• W2120332010 cites W2064113213 @default.
• W2120332010 cites W2087775691 @default.
• W2120332010 cites W2103687923 @default.
• W2120332010 cites W2106312755 @default.
• W2120332010 cites W2109614376 @default.
• W2120332010 cites W2112772060 @default.
• W2120332010 cites W2120864835 @default.
• W2120332010 cites W2124467386 @default.
• W2120332010 cites W2124891389 @default.
• W2120332010 cites W2126358767 @default.
• W2120332010 cites W2129148702 @default.
• W2120332010 cites W2133106296 @default.
• W2120332010 cites W2133240055 @default.
• W2120332010 cites W2138903976 @default.
• W2120332010 cites W2139248078 @default.
• W2120332010 cites W2141911743 @default.
• W2120332010 cites W2143359866 @default.
• W2120332010 cites W2145383415 @default.
• W2120332010 cites W2149228256 @default.
• W2120332010 cites W2153188415 @default.
• W2120332010 cites W2153544919 @default.
• W2120332010 cites W2154935592 @default.
• W2120332010 cites W2260050667 @default.
• W2120332010 cites W2333871875 @default.
• W2120332010 cites W4230207194 @default.
• W2120332010 doi "https://doi.org/10.1002/pbc.23075" @default.
• W2120332010 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3256281" @default.
• W2120332010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21509928" @default.
• W2120332010 hasPublicationYear "2011" @default.
• W2120332010 type Work @default.
• W2120332010 sameAs 2120332010 @default.
• W2120332010 citedByCount "30" @default.
• W2120332010 countsByYear W21203320102012 @default.
• W2120332010 countsByYear W21203320102013 @default.
• W2120332010 countsByYear W21203320102014 @default.
• W2120332010 countsByYear W21203320102015 @default.
• W2120332010 countsByYear W21203320102016 @default.
• W2120332010 countsByYear W21203320102017 @default.
• W2120332010 countsByYear W21203320102018 @default.
• W2120332010 countsByYear W21203320102019 @default.
• W2120332010 countsByYear W21203320102020 @default.
• W2120332010 countsByYear W21203320102021 @default.
• W2120332010 countsByYear W21203320102022 @default.
• W2120332010 countsByYear W21203320102023 @default.
• W2120332010 crossrefType "journal-article" @default.
• W2120332010 hasAuthorship W2120332010A5012423746 @default.
• W2120332010 hasAuthorship W2120332010A5026099902 @default.
• W2120332010 hasAuthorship W2120332010A5028072367 @default.
• W2120332010 hasAuthorship W2120332010A5034374604 @default.
• W2120332010 hasAuthorship W2120332010A5043293908 @default.
• W2120332010 hasAuthorship W2120332010A5045180889 @default.
• W2120332010 hasAuthorship W2120332010A5050739458 @default.
• W2120332010 hasAuthorship W2120332010A5053244337 @default.
• W2120332010 hasAuthorship W2120332010A5060308592 @default.
• W2120332010 hasAuthorship W2120332010A5070962895 @default.
• W2120332010 hasAuthorship W2120332010A5073277560 @default.
• W2120332010 hasAuthorship W2120332010A5085620590 @default.
• W2120332010 hasBestOaLocation W21203320102 @default.
• W2120332010 hasConcept C112705442 @default.
• W2120332010 hasConcept C121332964 @default.
• W2120332010 hasConcept C121608353 @default.

• next